Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL).
Francesco MalfonaAnna Maria TestiMaria Luisa MoletiLuigi PetrucciLucia LeccisottiMaurizio MartelliAlice Di RoccoPublished in: Leukemia & lymphoma (2021)